Valeant Picks Up Nicox's Diagnostics Unit
This article was originally published in The Gray Sheet
Executive Summary
Valeant will pay up to $20 million to gain Nicox's diagnostics unit, including a panel for Sjögren’s syndrome and a lab-developed test for age-related macular degeneration.